Latest news with #Wedgewood
Glasgow Times
25 minutes ago
- Entertainment
- Glasgow Times
The ultimate wedding gift guide that has everything covered
Buying presents for newly wed's can be a struggle if they don't have a wedding registry or you're just in need of some inspiration for a thoughtful gift they'll love. To help you out, we've rounded up a wide selection of gifts that everyone will love, no matter how picky they are. Plus, we've even saved you a job of hunting down the gift by adding links that take you straight to the item so you can buy it with plenty of time before the big day. From the couples who love to host to those who love an adventure, here's the ultimate wedding gift guide. For the adventurous couple: Experience Days If the soon-to-be-wed pair love an adventure, then Experience Days is the perfect option. You can book Britain's Highest Bungee Jump at 300ft, which is described as the perfect experience "that combines adrenaline and fear with an immense sense of reward on completion". The bungee costs £120 per person and can be booked via Experience Days. For the couples who love to host: Wedgwood Historic brand Wedgwood has some of the finest tableware you can buy, from striking designs to classic styles, it is described as offering the "very best". If you know a couple who loves to host, Wedgewood is the place to go, with options including the Hibiscus Serving Bowl for £185 and the Vera Wang Love Knows Tealight Holders for £60. Or, you could get the happy couple a new dinner set with the Renaissance Grey 5 Piece Dinner Set for £230. For the couples who love coffee: Royal Doulton For couples who love coffee and, even better, love a good set of mugs to enjoy their coffee from, Royal Doulton is a must. At Royal Doulton, you can buy a set of four Espresso Cups and Saucers for £55. For the couples who love a drink: Royal Doulton Royal Doulton is also the perfect place to go if the soon-to-be-married couple love to enjoy a drink or two. For £180, you can buy the couple the Seasons Decanter Set, made of a Decanter and 6 Tumbler Glasses via Royal Doulton. Recommended Reading For the couples who love to cook: Experience Days If the couple loves cooking, then a cooking class voucher with Experience Days makes the perfect gift. You can choose from a range of locations and types of classes. See the full range via the Experience Days website. The types of classes include tea blending, luxury chocolate making, cupcake baking, Vietnamese cooking, Thai cooking, authentic Chinese and a world cuisine cooking class. Prices range from below £100 and rise to above £500, with plenty of options on the affordable side as well. Locations for the classes include London, York, Glasgow, Cardiff, Edinburgh, Birmingham, Bristol and Oxford.
Yahoo
05-06-2025
- Business
- Yahoo
Wedgewood Pharmacy Adds GS-441524 to Its FIP Treatment Portfolio
SWEDESBORO, N.J., June 05, 2025--(BUSINESS WIRE)--Wedgewood Pharmacy today announced the availability of a GS-441524 formula, a compounded oral antiviral formulation now part of its feline infectious peritonitis (FIP) treatment capabilities. With this addition, veterinarians can now prescribe both GS-441524 and Molnupiravir for their patients, two of the most requested compounded antivirals for FIP, through a single trusted source backed by pharmacist support and FDA-registered ingredient sourcing. GS-441524 can be compounded as a 50mg/ml flavored oral oil suspension in multiple sizes, to improve compliance and ease of administration. The addition complements Wedgewood's Molnupiravir formulations, giving veterinarians access to two antivirals with distinct mechanisms of action. "FIP is one of the toughest diagnoses we face, not just clinically, but emotionally too," said Dr. Rae Hutchins, Chief Veterinary Officer at Wedgewood. "For a long time, vets had to deal with inconsistent access and quality when it came to GS-441524. Now, by offering both GS-441524 and Molnupiravir from one trusted, pharmacist-supported source, we're making it easier for veterinarians to focus on what matters most, giving their patients the best possible chance." "Having access to both GS-441524 and Molnupiravir compounded formulations through Wedgewood not only widens access to affordable FIP treatment across the US, but it also gives veterinarians the ability to easily choose and adapt treatment to best suit the needs of their patients and clients," said Nicole Jacque, co-founder of FIP Global Cats. "Having pharmacists who understand the urgency and complexity of these cases partnering with veterinarians is key to ensuring the best treatment outcomes for cats with FIP." Until recently, many veterinarians relied on fragmented or unregulated sources for GS-441524, making it difficult to ensure consistency and continuity of care. The introduction of this option through Wedgewood reflects a direct response to those challenges, providing prescribers with a trusted, quality-assured formulation from a pharmacy they can count on. The launch of GS-441524 builds on Wedgewood's long-standing role in supporting veterinarians with customized treatment solutions for complex cases. As part of its commitment to responsible compounding, the pharmacy emphasizes that its GS-441524 formulation is not approved by the FDA, has not been studied in clinical trials, and Wedgewood makes no claims of efficacy or safety. Independent third-party studies related to GS-441524 are available for veterinary reference through Wedgewood's FIP Resource Center. To learn more about GS-441524 and access educational resources, visit About WedgewoodWedgewood is the nation's largest and most trusted provider of compounded veterinary medications. Its next-generation home delivery platform, Blue Rabbit, streamlines patient care and marks a significant evolution in online pharmacy services. Together, Blue Rabbit and Wedgewood serve more than 70,000 veterinary professionals and more than one million animals annually. For more information visit About FIP Global Cats FIP Global CATS® (Community, Advocacy, Treatment, Support) is a leading organization in the fight against feline infectious peritonitis (FIP). Uniting veterinarians, researchers, and pet owners, it provides crucial support to those facing an FIP diagnosis. The organization is committed to empowering pet parents, advocating for safe, effective and affordable legal treatments, and advancing FIP research. For more information, please visit View source version on Contacts Jennifer Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
05-06-2025
- Business
- Business Wire
Wedgewood Pharmacy Adds GS-441524 to Its FIP Treatment Portfolio
SWEDESBORO, N.J.--(BUSINESS WIRE)--Wedgewood Pharmacy today announced the availability of a GS-441524 formula, a compounded oral antiviral formulation now part of its feline infectious peritonitis (FIP) treatment capabilities. With this addition, veterinarians can now prescribe both GS-441524 and Molnupiravir for their patients, two of the most requested compounded antivirals for FIP, through a single trusted source backed by pharmacist support and FDA-registered ingredient sourcing. "Having access to both GS-441524 and Molnupiravir compounded formulations through Wedgewood not only widens access to affordable FIP treatment across the US, but it also gives veterinarians the ability to easily choose and adapt treatment." Share GS-441524 can be compounded as a 50mg/ml flavored oral oil suspension in multiple sizes, to improve compliance and ease of administration. The addition complements Wedgewood's Molnupiravir formulations, giving veterinarians access to two antivirals with distinct mechanisms of action. 'FIP is one of the toughest diagnoses we face, not just clinically, but emotionally too,' said Dr. Rae Hutchins, Chief Veterinary Officer at Wedgewood. 'For a long time, vets had to deal with inconsistent access and quality when it came to GS-441524. Now, by offering both GS-441524 and Molnupiravir from one trusted, pharmacist-supported source, we're making it easier for veterinarians to focus on what matters most, giving their patients the best possible chance.' "Having access to both GS-441524 and Molnupiravir compounded formulations through Wedgewood not only widens access to affordable FIP treatment across the US, but it also gives veterinarians the ability to easily choose and adapt treatment to best suit the needs of their patients and clients,' said Nicole Jacque, co-founder of FIP Global Cats. 'Having pharmacists who understand the urgency and complexity of these cases partnering with veterinarians is key to ensuring the best treatment outcomes for cats with FIP.' Until recently, many veterinarians relied on fragmented or unregulated sources for GS-441524, making it difficult to ensure consistency and continuity of care. The introduction of this option through Wedgewood reflects a direct response to those challenges, providing prescribers with a trusted, quality-assured formulation from a pharmacy they can count on. The launch of GS-441524 builds on Wedgewood's long-standing role in supporting veterinarians with customized treatment solutions for complex cases. As part of its commitment to responsible compounding, the pharmacy emphasizes that its GS-441524 formulation is not approved by the FDA, has not been studied in clinical trials, and Wedgewood makes no claims of efficacy or safety. Independent third-party studies related to GS-441524 are available for veterinary reference through Wedgewood's FIP Resource Center. To learn more about GS-441524 and access educational resources, visit About Wedgewood Wedgewood is the nation's largest and most trusted provider of compounded veterinary medications. Its next-generation home delivery platform, Blue Rabbit, streamlines patient care and marks a significant evolution in online pharmacy services. Together, Blue Rabbit and Wedgewood serve more than 70,000 veterinary professionals and more than one million animals annually. For more information visit About FIP Global Cats FIP Global CATS® (Community, Advocacy, Treatment, Support) is a leading organization in the fight against feline infectious peritonitis (FIP). Uniting veterinarians, researchers, and pet owners, it provides crucial support to those facing an FIP diagnosis. The organization is committed to empowering pet parents, advocating for safe, effective and affordable legal treatments, and advancing FIP research. For more information, please visit
Yahoo
15-05-2025
- Business
- Yahoo
David Rolfe's Strategic Moves: UnitedHealth Group Inc. Sees Significant Reduction
David Rolfe (Trades, Portfolio) recently submitted the 13F filing for the first quarter of 2025, providing insights into his investment moves during this period. David Rolfe (Trades, Portfolio) has been managing Wedgewood's portfolio for 18 years. He studied at the University of Missouri and received a degree of B.S.B.A. in Finance/Economics in 1984. Wedgewood's underlying equity investment philosophy is predicated on a strong belief that significant long-term wealth will be created by investing as "owners" in companies. In its "Invest as Business Owners" approach, the firm seeks companies that have the following characteristics: A dominant product or service that is practically irreplaceable or lacks substitutes. A sustainable and consistent level of growing revenues, earnings, and dividends. A high level of profitability, measured by return on equity without the use of excessive debt. A strong management team that is shareholder-oriented. Warning! GuruFocus has detected 2 Warning Sign with TSM. David Rolfe (Trades, Portfolio) added a total of 1 stock, among them: The most significant addition was United Rentals Inc (NYSE:URI), with 24,829 shares, accounting for 3.57% of the portfolio and a total value of $17.71 million. David Rolfe (Trades, Portfolio) also increased stakes in a total of 12 stocks, among them: The most notable increase was S&P Global Inc (NYSE:SPGI), with an additional 10,731 shares, bringing the total to 34,091 shares. This adjustment represents a significant 45.94% increase in share count, a 1.11% impact on the current portfolio, and a total value of $17,452,630. The second largest increase was O'Reilly Automotive Inc (NASDAQ:ORLY), with an additional 4,129 shares, bringing the total to 12,593. This adjustment represents a significant 48.78% increase in share count, with a total value of $16,694,920. David Rolfe (Trades, Portfolio) also reduced positions in 7 stocks. The most significant changes include: Reduced UnitedHealth Group Inc (NYSE:UNH) by 45,082 shares, resulting in an -81.4% decrease in shares and a -4.49% impact on the portfolio. The stock traded at an average price of $511.2 during the quarter and has returned -47.37% over the past 3 months and -45.53% year-to-date. Reduced Edwards Lifesciences Corp (NYSE:EW) by 147,618 shares, resulting in a -43.49% reduction in shares and a -2.15% impact on the portfolio. The stock traded at an average price of $71.57 during the quarter and has returned 0.91% over the past 3 months and 3.85% year-to-date. At the first quarter of 2025, David Rolfe (Trades, Portfolio)'s portfolio included 20 stocks, with top holdings including 9.29% in Taiwan Semiconductor Manufacturing Co Ltd (NYSE:TSM), 9.24% in Meta Platforms Inc (NASDAQ:META), 8.26% in Alphabet Inc (NASDAQ:GOOGL), 7.06% in Apple Inc (NASDAQ:AAPL), and 7.04% in Microsoft Corp (NASDAQ:MSFT). The holdings are mainly concentrated in 6 of all the 11 industries: Technology, Communication Services, Financial Services, Industrials, Consumer Cyclical, and Healthcare. This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
15-04-2025
- Business
- Yahoo
What is being built near the Chandler Airpark?
Location: Loop 202 and Cooper Road in Chandler Description: Wedgewood, a veterinary pharmaceutical company and the parent company of online veterinary pharmacy platform Blue Rabbit, is nearing opening of their Chandler facility. The project is expected to house 250 jobs by 2027. The 90,000-square-foot facility will serve as a hub for rapid delivery and offer local pickup for Arizona pet owners. The facility is planned to eventually replace Wedgewood's smaller Arizona facility. History: The building is part of the second phase of the Chandler Airpark 202 business park, a 397,177-square-foot industrial project that includes three buildings. The project was proposed in 2021 and is part of the larger Chandler Airport Center master plan that was approved in 1999. Tenant improvements for Wedgewood began in February 2024. When will the work be done: The project is nearing completion, and it is scheduled to open in the first half of 2025. Sources: Arizona Commerce Authority, Vizzda, Cushman & Wakefield Like this story? Get more East Valley news straight into your email inbox by signing up for our free weekly East Valley Newsletter, which comes out on Wednesdays. Is there something under construction you'd like to tell us about or find out more about? Contact Corina Vanek at cvanek@ Follow her on X, formerly Twitter: @CorinaVanek. This article originally appeared on Arizona Republic: A veterinary pharmacy plans to create 250 jobs near Chandler Airpark
